The Journal of Infectious Diseases

Natural Boosting and the Immunogenicity of the XBB.1.5 Monovalent Vaccine in the Coronavirus Disease 2019 Endemic Era: A Longitudinal Observational Study

Pub Date : 2024-11-29 DOI: 10.1093/infdis/jiae536 Hyun Myung Kang, Hye-Jin Kim, Jiwon Jung, Jin Young Ahn, Kyoung-Ho Song, Jin Yang Baek, Ju-yeon Choi, Young Jae Lee, Hyeonji Jeong, Su-Hwan Kim, Soyoung Park, Hye Min Jang, Gi-eun Rhie, Eu Suk Kim, Jun Yong Choi, Sung-Han Kim, Eun-Suk Kang, Kyong Ran Peck, Hye Won Jeong, Jae-Hoon Ko

Development of high titer anti-drug antibodies in a Phase 1b/2a infant clesrovimab trial are associated with RSV exposure beyond day 150

Pub Date : 2024-11-26 DOI: 10.1093/infdis/jiae582 Nithya Thambi, Jia Yao Phuah, Ryan P Staupe, Lori M Tobias, Yu Cao, Troy McKelvey, Radha A Railkar, Antonios O Aliprantis, Carmen Sofia Arriola, Brian M Maas, Kalpit A Vora

Genetically diverse Mycobacterium tuberculosis isolates manipulate inflammasome activation and IL-1β secretion independently of macrophage metabolic rewiring

Pub Date : 2024-11-21 DOI: 10.1093/infdis/jiae583 Ana Isabel Fernandes, Alexandre Jorge Pinto, Diogo Silvério, Ulrike Zedler, Carolina Ferreira, Iola F Duarte, Ricardo Silvestre, Anca Dorhoi, Margarida Saraiva